Structural Heart Imaging (SHI) Market
By Imaging;
Echocardiogram and Angiogram - [Magnetic Resonance Imaging (MRI) and Computed Tomography (CT)]By Procedure;
TAVR, SAVR, TMVR, and LAACBy Application;
Diagnosis and SurgeryBy End-user;
Hospitals, Specialty Clinics, Cardiac Centers, Diagnostic Centers, Ambulatory Surgical Centers, and Catheterization Laboratories & OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Structural Heart Imaging (SHI) Equipment Market Overview
Structural Heart Imaging (SHI) Equipment Market (USD Million)
Structural Heart Imaging (SHI) Equipment Market was valued at USD 19,154.06 million in the year 2024. The size of this market is expected to increase to USD 41,817.06 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 11.8%.
Structural Heart Imaging (SHI) Market
*Market size in USD million
CAGR 11.8 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 11.8 % |
Market Size (2024) | USD 19,154.06 Million |
Market Size (2031) | USD 41,817.06 Million |
Market Concentration | Low |
Report Pages | 321 |
Major Players
- CardioComm Solutions Inc.
- Circle Cardiovascular Imaging, Inc.
- HeartSciences
- Koninklijke Philips N.V.
- Pie Medical Imaging
- Shimadzu Corporation
- Siemens Healthineers
- TomTec Imaging Systems GmbH
- Toshiba Corporation
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Structural Heart Imaging (SHI) Market
Fragmented - Highly competitive market without dominant players
The Structural Heart Imaging (SHI) Equipment Market is undergoing rapid growth, fueled by a surge in cardiovascular interventions that demand high-precision diagnostics. As heart valve diseases and congenital abnormalities rise, more than 65% of interventional procedures are now supported by structural imaging technologies. These systems are becoming crucial in enhancing pre-procedural planning and post-treatment outcomes.
Technological Advancements
Innovation in SHI equipment is driving transformative changes, with over 40% of solutions now incorporating AI algorithms and 3D capabilities. These tools enhance diagnostic accuracy and procedural clarity. The growing use of hybrid modalities is helping clinicians evaluate both structure and function, positioning next-gen imaging as a cornerstone in interventional cardiology
Clinical Demand Drivers
The increasing need for image-guided heart procedures has fueled a 55% spike in demand for SHI platforms. These systems are essential in managing high-risk patients and guiding complex transcatheter therapies. Hospitals are investing in integrated solutions that combine diagnostics and navigation, which is boosting procedural safety and decision-making efficiency.
Operational Benefits
Advanced SHI equipment has led to 48% improvement in clinical throughput and intraoperative guidance. Real-time visualization tools minimize complications and enable clinicians to adapt treatment strategies swiftly. The systems are supporting individualized care pathways, aligning with the global trend toward patient-specific therapy approaches.
Future Outlook
The SHI market is expected to benefit from a 35% increase in funding for innovation, focused on miniaturization, interoperability, and cloud-enabled imaging. Collaborations among device manufacturers and cardiovascular institutions are driving faster development cycles, ensuring that future imaging technologies remain both adaptable and data-centric.
Structural Heart Imaging (SHI) Equipment Market Recent Developments
-
In December 2024, Siemens Healthineers secured FDA clearance for a next-gen cardiac CT scanner featuring improved soft-tissue resolution and lower radiation exposure, elevating accuracy in structural heart imaging.
-
In August 2024, Edwards Lifesciences expanded its imaging portfolio by acquiring JenaValve Technology, incorporating pioneering transcatheter solutions for aortic regurgitation into its structural heart intervention offerings.
Structural Heart Imaging (SHI) Equipment Market Segment Analysis
In this report, the Structural Heart Imaging (SHI) Equipment Market has been segmented by Imaging, Procedure, Application, End-user, and Geography.
Structural Heart Imaging (SHI) Equipment Market, Segmentation by Imaging
The Structural Heart Imaging (SHI) Equipment Market has been segmented by Imaging into Echocardiogram & Angiogram - Magnetic Resonance Imaging (MRI) and Computed Tomography (CT).
Echocardiogram & Angiogram
Echocardiogram & angiogram imaging accounts for approximately 55% of the structural heart imaging equipment market in 2024. These modalities provide real-time visualization of cardiac anatomy and blood flow, essential for structural heart disease diagnosis and interventional planning. Technological advancements in 3D imaging and contrast-enhanced studies are fueling growth.
Magnetic Resonance Imaging (MRI)
MRI holds around 25% of the market share, offering superior soft tissue characterization and detailed anatomical assessments for complex cardiac cases. It provides valuable information for pre-surgical planning and post-procedural monitoring. The growing availability of advanced MRI systems with cardiac-specific protocols is boosting adoption.
Computed Tomography (CT)
CT imaging represents approximately 20% of the SHI equipment market. It delivers high-resolution images and rapid acquisition times, making it ideal for coronary artery visualization and valve assessment. The increasing use of multi-slice CT and advanced reconstruction techniques enhances diagnostic accuracy and supports its expanding use in structural heart interventions.
Structural Heart Imaging (SHI) Equipment Market, Segmentation by Procedure
The Structural Heart Imaging (SHI) Equipment Market has been segmented by Procedure into TAVR, SAVR, TMVR, and LAAC
TAVR
Transcatheter Aortic Valve Replacement (TAVR) is a minimally invasive procedure commonly used to treat aortic valve stenosis in high-risk or elderly patients. This method accounts for over 65% of total aortic valve replacement cases, driven by rising geriatric population and advancements in catheter-based imaging.
SAVR
Surgical Aortic Valve Replacement (SAVR) remains a key option for younger or lower-risk patients due to its long-term durability. Despite growing preference for minimally invasive alternatives, SAVR still constitutes around 30% of procedures, supported by its proven clinical outcomes.
TMVR
Transcatheter Mitral Valve Replacement (TMVR) is a developing solution for patients with mitral valve disease unsuitable for open surgery. The segment is growing at over 12% annually, thanks to expanding clinical trials and innovations in mitral valve delivery systems.
LAAC
Left Atrial Appendage Closure (LAAC) is increasingly used to reduce the risk of stroke in atrial fibrillation patients. This procedure is seeing a steady rise in adoption due to its preventive benefits and advancements in minimally invasive cardiac interventions.
Structural Heart Imaging (SHI) Equipment Market, Segmentation by Application
The Structural Heart Imaging (SHI) Equipment Market has been segmented by Application into Diagnosis and Surgery
Diagnosis
Diagnostic applications in the Structural Heart Imaging (SHI) Equipment Market are essential for identifying structural abnormalities such as valve disorders, septal defects, and congenital heart anomalies. This segment dominates the market with over 60% share, driven by the growing use of advanced imaging technologies like 3D echocardiography and cardiac MRI.
Surgery
Surgical applications of SHI equipment support precise intraoperative guidance during cardiac interventions such as TAVR, TMVR, and LAAC. With increasing adoption of minimally invasive procedures, this segment is witnessing strong growth, contributing to nearly 40% of the overall market.
Structural Heart Imaging (SHI) Equipment Market, Segmentation by End-user
The Structural Heart Imaging (SHI) Equipment Market has been segmented by End-user into Hospitals, Specialty Clinics, Cardiac Centers, Diagnostic Centers, Ambulatory Surgical Centers, and Catheterization Laboratories & Others
Hospitals
Hospitals represent the largest end-user segment, accounting for over 45% of the Structural Heart Imaging (SHI) Equipment Market. Their broad infrastructure and access to advanced cardiac imaging systems make them pivotal in both diagnostic and surgical procedures.
Specialty Clinics
Specialty clinics focus on treating specific cardiovascular conditions and are increasingly adopting SHI equipment for precise imaging. Their demand is supported by a rise in outpatient cardiac care and cost-efficient diagnostic solutions.
Cardiac Centers
Cardiac centers are dedicated to heart-related treatments and often equipped with state-of-the-art imaging systems. These centers play a critical role in complex structural heart disease evaluations and interventions.
Diagnostic Centers
Diagnostic centers offer non-invasive cardiac imaging services such as echocardiography and CT/MRI scans. With increasing demand for early detection, these centers contribute to nearly 15% of the market share.
Ambulatory Surgical Centers
Ambulatory Surgical Centers (ASCs) are gaining traction due to their cost-effectiveness and shorter procedure times. They are gradually adopting SHI equipment to support minimally invasive cardiac procedures.
Catheterization Laboratories & Others
Catheterization laboratories (Cath labs) and other healthcare facilities use SHI tools for real-time imaging during interventional procedures. These settings support both diagnostic accuracy and precision-guided treatment, contributing to the market’s specialized segment.
Structural Heart Imaging (SHI) Equipment Market, Segmentation by Geography
In this report, the Structural Heart Imaging (SHI) Equipment Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
Structural Heart Imaging (SHI) Equipment Market Share (%), by Geographical Region
North America
North America dominates the structural heart imaging equipment market with a share of approximately 40% in 2024. The region benefits from a strong presence of advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and rapid adoption of innovative imaging technologies. Investments in research and development and favorable reimbursement policies further support growth.
Europe
Europe holds around 28% of the global market share, driven by a growing aging population and increasing focus on early disease detection. The demand for advanced diagnostic imaging solutions and strong regulatory support for cardiac imaging technologies contribute to market expansion. Collaborative efforts in clinical research and innovation boost adoption.
Asia Pacific
Asia Pacific accounts for approximately 20% of the market, experiencing rapid growth due to rising healthcare investments and expanding medical infrastructure. Countries like China and India are key contributors, supported by increasing awareness of cardiovascular health and a rising burden of chronic diseases. The adoption of advanced imaging modalities is expected to grow.
Middle East and Africa
The Middle East and Africa contribute about 7% of the market share, driven by government initiatives to upgrade healthcare infrastructure and rising awareness of cardiovascular diseases. The growing adoption of advanced imaging equipment in private and public healthcare facilities supports market growth in this region.
Latin America
Latin America represents around 5% of the structural heart imaging equipment market, with growth driven by expanding healthcare access and increasing investment in diagnostic technologies. Countries like Brazil and Mexico are leading adoption, focusing on enhancing cardiovascular care and imaging capabilities.
Structural Heart Imaging (SHI) Equipment Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Structural Heart Imaging (SHI) Equipment Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces—Drivers, Restraints, and Opportunities—affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
---|---|---|---|---|---|
Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers
- Adoption of advanced imaging modalities
- Improved diagnostic precision levels
-
Growth in non-invasive techniques - The rising preference for non-invasive diagnostic methods is significantly driving the demand for structural heart imaging (SHI) equipment. Patients and healthcare providers increasingly favor procedures that reduce surgical risks, minimize recovery times, and avoid hospitalization. Non-invasive imaging techniques such as echocardiography, CT, and cardiac MRI offer accurate visualization of heart structures without requiring invasive catheterization, making them essential tools in modern cardiovascular diagnostics.
This shift is supported by advancements in imaging technologies that have improved resolution, speed, and accessibility of real-time cardiac evaluations. As healthcare systems focus on early and accurate detection of structural heart conditions, the integration of non-invasive imaging systems into clinical pathways becomes more prevalent. The growing adoption of these techniques not only enhances patient comfort and outcomes but also contributes to increased efficiency in diagnosis and treatment planning—solidifying their role as a key growth driver in the SHI equipment market.
Restraints
- Limited accessibility to imaging technologies
- Ongoing patient safety concerns
-
Presence of imaging artifacts - The presence of imaging artifacts remains a significant limitation in the use of structural heart imaging (SHI) equipment, as these distortions can compromise the accuracy of diagnostic results. Artifacts, caused by factors such as patient movement, prosthetic materials, or improper calibration, may obscure critical cardiac structures or mimic pathologies. This can lead to misinterpretation of data, delayed diagnosis, or even incorrect treatment planning, affecting the overall reliability of non-invasive imaging techniques.
As clinicians rely on high-resolution imaging to assess complex cardiac abnormalities, the occurrence of artifacts presents a challenge to maintaining diagnostic precision. Despite technological advancements, certain imaging modalities like CT and ultrasound remain susceptible to technical limitations. These issues highlight the need for continuous development in software correction tools and operator training to minimize artifact-related discrepancies. Until addressed effectively, the presence of imaging artifacts will continue to restrain the optimal use of SHI equipment in clinical settings.
Opportunities
- Continuous technological advancements
- Expansion of market growth
-
Rising demand for minimally invasive procedures - The growing preference for minimally invasive procedures is generating significant opportunities for the structural heart imaging (SHI) equipment market. These procedures are favored for their ability to reduce patient recovery time, hospital stays, and surgical risks. To ensure the precision of such interventions, there is an increasing dependence on advanced imaging technologies like 3D echocardiography, cardiac CT, and MRI, which help guide catheter-based therapies and provide real-time visualization of complex heart structures.
The expansion of procedures like transcatheter valve replacements and minimally invasive cardiac repairs is driving the need for accurate and high-resolution imaging. As the burden of structural heart diseases rises—particularly among the aging population—healthcare providers are increasingly investing in SHI systems that enhance procedural outcomes and reduce complication rates. This growing alignment between non-surgical interventions and advanced imaging solutions positions the SHI equipment market for sustained growth and innovation.
Structural Heart Imaging (SHI) Equipment Market Competitive Landscape Analysis
Key players in Structural Heart Imaging (SHI) Equipment Market include:
- General Electric Company (GE HealthCare)
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- Hitachi, Ltd.
- Shimadzu Corporation
- Esaote S.p.A.
- FUJIFILM Holdings Corporation
- Samsung Medison Co., Ltd.
- Carestream Health, Inc.
- Mindray Medical International Limited
- Pie Medical Imaging (including 3mensio)
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Market Share Analysis
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Imaging
- Market Snapshot, By Procedure
- Market Snapshot, By Application
- Market Snapshot, By End-user
- Market Snapshot, By Region
- Structural Heart Imaging (SHI) Equipment Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Adoption of advanced imaging modalities
-
Improved diagnostic precision levels
-
Growth in non-invasive techniques
-
- Restraints
-
Limited accessibility to imaging technologies
-
Ongoing patient safety concerns
-
Presence of imaging artifacts
-
- Opportunities
-
Continuous technological advancements
-
Expansion of market growth
-
Rising demand for minimally invasive procedures
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Structural Heart Imaging (SHI) Equipment Market, By Imaging, 2021 - 2031 (USD Million)
- Echocardiogram
- Angiogram
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
-
Structural Heart Imaging (SHI) Equipment Market, By Procedure, 2021 - 2031 (USD Million)
-
TAVR
-
SAVR
-
TMVR
-
LAAC
-
-
Structural Heart Imaging (SHI) Equipment Market, By Application, 2021 - 2031 (USD Million)
-
Diagnosis
-
Surgery
-
-
Structural Heart Imaging (SHI) Equipment Market, By End-user, 2021 - 2031 (USD Million)
-
Hospitals
-
Specialty Clinics
-
Cardiac Centers
-
Diagnostic Centers
-
Ambulatory Surgical Centers
-
Catheterization Laboratories
-
Others
-
- Structural Heart Imaging (SHI) Equipment Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN(Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Structural Heart Imaging (SHI) Equipment Market, By Imaging, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- General Electric Company (GE HealthCare)
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- Hitachi, Ltd.
- Shimadzu Corporation
- Esaote S.p.A.
- FUJIFILM Holdings Corporation
- Samsung Medison Co., Ltd.
- Carestream Health, Inc.
- Mindray Medical International Limited
- Pie Medical Imaging (including 3mensio)
- Company Profiles
- Analyst Views
- Future Outlook of the Market